Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Aeterna Zentaris Inc. (AEZS) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/28/2021 GN Aeterna Zentaris Announces Virtual 2021 Annual Meeting of Shareholders
03/25/2021 GN Aeterna Zentaris Reports Fourth Quarter and Full Year 2020 Financial Results
03/22/2021 GN Aeterna Zentaris Regains Compliance with Nasdaq Minimum Bid Price Requirement
03/15/2021 GN Aeterna Zentaris Announces Exclusive License Agreement and Research Contract with Julius-Maximilians-University Wuerzburg for Development of a Potential Oral Prophylactic Bacterial Vaccine Against COVID-19
03/11/2021 GN Aeterna Zentaris Continues to Demonstrate Pipeline Expansion – Announces the Initiation of Its Preclinical Program for the Potential Treatment of Primary Hypoparathyroidism
02/24/2021 GN Aeterna Zentaris to Present at the H.C. Wainwright Global Life Sciences Conference
02/19/2021 GN Aeterna Zentaris Announces Closing of $29.7 Million Bought Deal Offering of Common Shares
02/16/2021 GN Aeterna Zentaris Increases Previously Announced Bought Deal Offering of Common Shares to $29.7 Million
02/16/2021 GN Aeterna Zentaris Announces $10.0 Million Bought Deal Offering of Common Shares
02/02/2021 GN Aeterna Zentaris Announces Evaluation and Potential Development of an Oral Prophylactic Bacterial Vaccine Against COVID-19 Through Exclusive Option Agreement with Julius-Maximilians-University Wuerzburg
01/28/2021 GN Aeterna Zentaris Expands Orphan Drug Development Pipeline with Targeted Immunosuppressive Therapeutics
01/26/2021 GN Aeterna Zentaris Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
01/05/2021 GN Aeterna Zentaris to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference
12/07/2020 GN Aeterna Zentaris Announces European Licensing Agreement with Consilient Health Ltd. for Commercialization of Macimorelin
11/06/2020 GN Aeterna Zentaris Reports Third Quarter 2020 Financial Results and Provides Business Update
09/08/2020 GN Aeterna Zentaris Announced Presentation of Positive Results from First Pediatric Study of Macimorelin at the 22nd European Congress of Endocrinology
08/06/2020 GN Aeterna Zentaris Reports Second Quarter 2020 Financial Results and Provides Business Update
08/05/2020 GN Aeterna Zentaris Announces Closing of $7.0 Million Registered Direct Offering Priced At-The-Market
08/03/2020 GN AETERNA ZENTARIS ANNOUNCES $7.0 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET
07/31/2020 GN Aeterna Zentaris Announces Continued Expansion of Intellectual Property Portfolio for Macimorelin with Additional Patent Applications
07/29/2020 GN Aeterna Zentaris Receives Nasdaq Notification Regarding Minimum Bid Price Compliance; No Immediate Impact on Listing
07/07/2020 GN AETERNA ZENTARIS ANNOUNCES CLOSING OF $12 MILLION PUBLIC OFFERING
07/01/2020 GN AETERNA ZENTARIS ANNOUNCES PRICING OF $12 MILLION PUBLIC OFFERING
06/08/2020 GN Aeterna Zentaris Regains Compliance With Nasdaq Minimum Bid Price Requirement
06/04/2020 GN Aeterna Zentaris Receives Extension From Nasdaq to Satisfy Continuing Listing Requirements
05/15/2020 GN Aeterna Zentaris Announces Results of 2020 Annual Meeting of Shareholders
05/08/2020 GN Aeterna Zentaris Announces Virtual 2020 Annual Meeting of Shareholders
05/06/2020 GN Aeterna Zentaris Reports First Quarter 2020 Financial and Operating Results
04/15/2020 GN Aeterna Zentaris Receives Nasdaq Notice of Non-Compliance; No Immediate Impact on Listing
04/15/2020 GN Aeterna Zentaris to Present at the April 2020 Virtual Investor Summit
04/07/2020 GN AETERNA ZENTARIS ANNOUNCES EMA DECISION TO ACCEPT A MODIFICATION TO AN AGREED PEDIATRIC INVESTIGATION PLAN FOR MACIMORELIN
04/06/2020 GN AETERNA ZENTARIS ANNOUNCES POSITIVE RESULTS IN DOSE-FINDING PEDIATRIC STUDY OF MACIMORELIN
03/30/2020 GN AETERNA ZENTARIS REPORTS FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL AND OPERATING RESULTS AND PROVIDES BUSINESS UPDATE
03/12/2020 GN AETERNA ZENTARIS ANNOUNCES SETTLEMENT OF PREVIOUSLY DISCLOSED CLASS-ACTION LAWSUIT
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy